New miracle weapon against obesity: Graz is testing innovative syringes!

New miracle weapon against obesity: Graz is testing innovative syringes!

History is being written in Graz: The new generation of weight loss injection, a further development of the weight loss hit Ozempic, is currently being tested at MedUni Graz. This innovative therapy has the potential to make weight loss significantly more efficient by acting on two appetite regulators instead of just one. According to the experts, there is talk of a possible weight loss of up to 25 percent, which represents hope for many overweight people. The initiative is an important step in the fight against the growing obesity epidemic, which could affect around 51 percent of the world's population by 2035, according to the World Obesity Atlas the small newspaper reported.

Morbid overweight, also known as obesity, has devastating health consequences – including diabetes, cardiovascular disease and joint problems. Thomas Pieber, head of the Department of Endocrinology at the LKH University Hospital Graz, emphasizes that being overweight not only increases the risk of many diseases, but also accelerates the aging process. The MedUni Graz team, together with research partners from the University of Graz and MedUni Vienna, is actively involved in the search for solutions for healthy aging with regard to metabolism within the Cluster of Excellence Metabolic Control of Aging and Disease (MetAGE). Today.at reported.

Looking for volunteers for the study

In order to research the optimal effect and dosage of the new injection, healthy, non-childbearing women and men between the ages of 18 and 64 with a body mass index (BMI) between 27 and 44.9 are currently being sought as voluntary participants. This could be a great opportunity for many in this age group to become part of a potentially groundbreaking project that could revolutionize the way we deal with obesity.